Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cells

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1919-1924

  Iacopino, Fortunata ^a   Ferrandina, Gabriella ^a   Scambia, Giovanni ^a   Benedetti Panici, Pierluigi ^a   Mancuso, Salvatore ^a   Sica, Gigliola ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Breast cancer cells; Epidermal Growth Factor; Epidermal Growth Factor receptors; Interferons

Indexed keywords

BETA INTERFERON; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; RECOMBINANT ALPHA2B INTERFERON;

ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN BINDING;

BREAST NEOPLASMS; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON ALFA-2B; INTERFERON-BETA; KINETICS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 0029782128     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Salle V, Souttou B, Magnien V, Israel L, Crépin M: Facteurs de croissance des cellules épithéliales de mastopathies et de carcinomes du sein en primoculture. Bull Cancer 79: 133-140, 1992.
2. Dittadi R, Donisi PM, Brazzale A, Cappellozza L, Bruscagnin G. Gion M: Epidermal growth factor receptor in breast cancer. Comparison with non malignant breast tissue. Br J Cancer 67: 7-9, 1993.
3. Stoscheck CM, King LE Jr: Role of epidermal growth factor in carcinogenesis. Cancer Res 46: 1030-1037, 1986.
4. Kern FG, Cheville AL, Liu Y: Growth factor receptors and the progression of breast cancer. Semin Cancer Biol 1: 317-328, 1990.
5. Battaglia F, Scambia G, Rossi S, Benedetti Panici P, Bellantone R, Polizzi G, Querzoli P, Negrini R, Iacobelli S, Crucitti F, Mancuso S: Epidermal growth factor receptor in human breast cancer: correlation with steroid hormone receptors and axillary lymph node involvement. Eur J Cancer Clin Oncol 24: 1685-1690, 1988.
6. Davidson NE, Gelmann EP, Lippman ME, Dickson RB: Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol 1: 216-223, 1987.
7. Valverius EM, Velu T, Shankar V, Ciardiello F, Kim N, Salomon DS: Overexpression of the epidermal growth factor receptor in human breast cancer cells fails to induce an estrogen-independent phenotype. Int J Cancer 46: 712-718, 1990.
8. Dickstein B, Valverius EM, Wosikowski K, Saceda M, Pearson JW, Martin MB, Bates SE: Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7 cell line. J Cell Physiol 157: 110-118, 1993.
9. van den Berg HW, Leahey WJ, Lynch M, Clarke R, Nelson J: Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitises them to the anti-proliferative effects of tamoxifen. Br J Cancer 55: 255-257, 1987.
10. Sica G, Natoli V, Stella C, Del Bianco S: Effect of natural beta-interferon on cell proliferation and steroid receptor level in human breast cancer cells. Cancer 60: 2419-2423, 1987.
11. Bezwoda WR, Meyer K: Effect of α-interferon. 17ß-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF-7 cells. Cancer Res 50: 5387-5391, 1990.
12. Solary E, Prud'homme JF, Gauville C, Magdelenat H, Calvo F: Modulation of proliferation, estradiol receptors and estrogen regulated protein PS2/BCEI in human breast cancer cell lines by gamma interferon. J Biol Regul Homeost Agents 5: 98-106, 1991.
13. Sica G, Iacopino F, Robustelli della Cuna G, Marchetti P: Recombinant interferon α2b affects proliferation, steroid receptors and sensitivity to tamoxifen of cultured breast cancer cells (CG-5). Anti-Cancer Drugs 3: 147-153, 1992.
14. Pouillart P, Palangie T, Jouve M, Garcia-Giralt E, Fridman WH, Magdelenat H, Falcoff E, Billiau A: Administration of fibroblast interferon to patients with advanced breast cancer: possible effects on skin metastasis and on hormone receptors. Eur J Cancer Clin Oncol 18: 929-935, 1982.
15. Sica G, Iacopino F, Lama G, Amadori D, Baroni M, Lo Sardo F, Malacarne P, Marchetti P, Pellegrini A, Zaniboni A, Robustelli della Cuna G: Steroid receptor enhancement by natural beta-interferon in advanced breast cancer. Eur J Cancer 29A: 329-333, 1993.
16. Seymour L, Bezwoda WR: Interferon plus tamoxifen treatment for advanced breast cancer: in vivo biologic effects of two growth modulators. Br J Cancer 68: 352-356, 1993.
17. Zoon KC, Karasaki Y, zur Nedden DL, Hu R, Arnheiter H: Modulation of epidermal growth factor receptors by human α interferon. Proc Natl Acad Sci USA 83: 8226-8230, 1986.
18. Eisenkraft BL, Nanus DM, Albino AP, Pfeffer LM: α-interferon down-regulates epidermal growth factor receptors on renal carcinoma cells: relation to cellular responsiveness to the antiproliferative action of α-interferon. Cancer Res 51: 5881-5887, 1991.
19. Budillon A, Tagliaferri P, Caraglia M, Torrisi MR, Normanno N, lacobelli S, Palmieri G, Stoppelli MP, Frati L, Bianco AR: Upregulation of epidermal growth factor receptor induced by α-interferon in human epidermoid cancer cells. Cancer Res 51: 1294-1299, 1991.
20. Chakravarthy A, Chen LC, Mehta D, Hamburger AW: Modulation of epidermal growth factor receptors by gamma interferon in a breast cancer cell line. Anticancer Res 11: 347-352, 1991.
21. Chakravarthy A, Pollak M, Hamburger AW: Interferon-induced modulation of epidermal growth factor-stimulated growth of a human breast tumor cell line. J Interferon Res 11: 1-8, 1991.
22. Hamburger AW, Pinnamaneni GD: Increased epidermal growth factor receptor gene expression by γ-interferon in a human breast carcinoma cell line. Br J Cancer 64: 64-68, 1991.
23. 3. Chemother 40: 51-56, 1994.
24. Filmus J, Trent JM, Pollak MN, Buick RN: Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants. Mol Cell Biol 7: 251-257, 1987.
25. Natoli C, Sica G, Natoli V, Serra A, Iacobelli S: Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line. Breast Cancer Res Treat 3: 23-32, 1983.
26. Koenders PG, Faverly D, Beex LVAM, Bruggink EDM, Kienhuis CBM, Benraad ThJ: Epidermal growth factor receptors in human breast cancer: a plea for standardisation of assay methodology. Eur J Cancer 28: 693-697, 1992.
27. Fitzpatrick SL, LaChance MP, Schultz GS: Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res 44: 3442-3447, 1984.
28. Filmus J, Pollak MN, Cailleau R, Buick RN: MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Comm 128: 898-905, 1985.
29. Lin SL, Ts'o POP, Hollemberg MD: The effect of Interferon on epidermal growth factor action. Biochem Biophys Res Commun 96: 168-174, 1980.
30. 3 in human breast cancer cells. Cancer Res 48: 2734-2739, 1988.
31. Kim JS, Steck PA, Gallick GE, Lee JS, Blick M, Hong WK, Lotan R: Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells. Monogr Natl Cancer Inst 13: 101-110, 1992.
32. Benoit P, Maguire D, Plavec 1, Kocher H, Tovey M, Meyer F: A monoclonal antibody to recombinant human IFN-α receptor inhibits biologic activity of several species of human IFN-α, IFN-β, and IFN-ω. J Immunol 150: 707-716, 1993.
33. Kontsek P: Human type I interferons: structure and function. Acta Virol. 38: 345-360, 1994.
34. Scambia G, Benedetti Panici P, Ferrandina G, Battaglia F, Sica G, Coronetta F. Rumi C, Mancuso S: Effect of recombinant human interferon-alpha/2b on epidermal-growth-factor-, estrogen- and progesterone-receptor expression in primary cervical cancer. Int J Cancer 58: 769-773, 1994.
35. Scambia G, Benedetti Panici P, Battaglia F, Ferrandina G, Baiocchi G, Gallo A, Sica G, Mancuso S: Effect of recombinant human interferon-alpha2b on receptors for steroid hormones and epidermal growth factor in patients with endometrial cancer. EurJ Cancer 27: 51-53, 1991.
36. Chang EH, Black R, Zou ZQ, Masnyk T, Ridge J, Noguchi P, Harford JB: γ-interferon modulates growth of A431 cells and expression of EGF receptors. In: Interferons as cell growth inhibitors and antitumor factors (Friedman RM, Merigan T, Sreevalsan T, eds) New York, Alan R. Liss, Inc, 1986, pp. 335-349.